These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 22971190

  • 1. Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis.
    Knobler R, Duvic M, Querfeld C, Straus D, Horwitz S, Zain J, Foss F, Kuzel T, Campbell K, Geskin L.
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):250-7. PubMed ID: 22971190
    [Abstract] [Full Text] [Related]

  • 2. Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience.
    Siakantaris MP, Tsirigotis P, Stavroyianni N, Argyropoulos KV, Girkas K, Pappa V, Chondropoulos S, Papadavid E, Sakellari I, Anagnostopoulos A, Antoniou C, Dervenoulas J.
    Transfus Apher Sci; 2012 Apr; 46(2):189-93. PubMed ID: 22178592
    [Abstract] [Full Text] [Related]

  • 3. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
    Bisaccia E, Gonzalez J, Palangio M, Schwartz J, Klainer AS.
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
    [Abstract] [Full Text] [Related]

  • 4. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
    Wilson LD, Jones GW, Kim D, Rosenthal D, Christensen IR, Edelson RL, Heald PW, Kacinski BM.
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224
    [Abstract] [Full Text] [Related]

  • 5. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
    Prinz B, Behrens W, Hölzle E, Plewig G.
    Arch Dermatol Res; 1995 Jul; 287(7):621-6. PubMed ID: 8534123
    [Abstract] [Full Text] [Related]

  • 6. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
    Bisaccia E, Vonderheid EC, Geskin L.
    Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
    [Abstract] [Full Text] [Related]

  • 7. The treatment of cutaneous T-cell lymphoma with photopheresis.
    Zic JA.
    Dermatol Ther; 2003 Jul; 16(4):337-46. PubMed ID: 14686977
    [Abstract] [Full Text] [Related]

  • 8. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
    Quaglino P, Knobler R, Fierro MT, Savoia P, Marra E, Fava P, Bernengo MG.
    Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy.
    Zic JA, Stricklin GP, Greer JP, Kinney MC, Shyr Y, Wilson DC, King LE.
    J Am Acad Dermatol; 1996 Dec; 35(6):935-45. PubMed ID: 8959953
    [Abstract] [Full Text] [Related]

  • 10. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
    Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG, Lessin SR, Rook AH.
    J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954
    [Abstract] [Full Text] [Related]

  • 11. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L.
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [Abstract] [Full Text] [Related]

  • 12. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E, Palangio M, Gonzalez J, Adler KR, Scarborough R, Goldberg SL, Rowley SD.
    J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ, Mitchell TJ, Whittaker SJ, Scarisbrick JJ, Seed PT, Russell-Jones R.
    Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Extracorporeal photopheresis and multimodality therapy in patients with T-cell cutaneous lymphomas: Real-life experience in Argentina.
    Baquero Rey JA, Zambrano Franco EA, Andrade Miranda A, Marciano S, Mazzuoccolo LD, Enz PA.
    J Clin Apher; 2021 Dec; 36(6):815-822. PubMed ID: 34478581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.